New Bioprocessing Standards from Molecule to Market

摘要

Life Technologies is at the forefront of a quest to improve the human condition. Growing numbers of biotherapeutics, revolutionary blood products, emerging biosimilars, and a vaccine industry moving toward cell culture-based production systems all promise to transform traditional disease treatment. Leveraging core expertise in cell culture, downstream purification, and rapid molecular-based contaminant testing, Life Technologies offers biotherapeutic and vaccine production solutions under trusted GIBCO~R and Applied Biosystems~R brands.